dc.contributor.author | Dalkiran, A. | |
dc.contributor.author | Tasova, Y | |
dc.contributor.author | Bayram, H. | |
dc.contributor.author | Tetiker, T. | |
dc.contributor.author | SALTOĞLU, Neşe | |
dc.contributor.author | Sert, M. | |
dc.contributor.author | Dalay, C. | |
dc.date.accessioned | 2021-03-04T19:08:20Z | |
dc.date.available | 2021-03-04T19:08:20Z | |
dc.identifier.citation | SALTOĞLU N., Dalkiran A., Tetiker T., Bayram H., Tasova Y., Dalay C., Sert M., "Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomised clinical trial in a university hospital", 18 th European Congress Clinical Microbiology Infectious Diseases, Barselona, İspanya, 14 - 22 Nisan 2008, ss.2518 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_8e49e684-4ad7-471f-8ba0-2e3d7002a613 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/96135 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.title | Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomised clinical trial in a university hospital | |
dc.type | Bildiri | |
dc.contributor.department | Çukurova Üniversitesi , , | |
dc.contributor.firstauthorID | 338663 | |